Equities

Mochida Pharmaceutical Co Ltd

Mochida Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,305.00
  • Today's Change5.00 / 0.15%
  • Shares traded500.00
  • 1 Year change+0.61%
  • Beta0.2498
Data delayed at least 20 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments46,78960,50961,914
Total Receivables, Net34,83827,80631,676
Total Inventory30,27824,40423,127
Prepaid expenses------
Other current assets, total4,7574,6604,731
Total current assets116,662117,379121,448
Property, plant & equipment, net15,87415,04914,528
Goodwill, net------
Intangibles, net721797713
Long term investments16,11614,24616,474
Note receivable - long term------
Other long term assets7,0557,4776,285
Total assets158,800158,831163,139
LIABILITIES
Accounts payable12,1829,95711,899
Accrued expenses2,1402,3132,663
Notes payable/short-term debt000
Current portion long-term debt/capital leases26120
Other current liabilities, total11,72514,97615,294
Total current liabilities26,07327,25829,856
Total long term debt3431780
Total debt3691900
Deferred income tax------
Minority interest------
Other liabilities, total4,4174,6204,637
Total liabilities30,83332,05634,493
SHAREHOLDERS EQUITY
Common stock7,2297,2297,229
Additional paid-in capital1,8711,8711,871
Retained earnings (accumulated deficit)117,022118,943121,668
Treasury stock - common(7021)(7114)(9617)
Unrealized gain (loss)8,5855,6557,308
Other equity, total281191187
Total equity127,967126,775128,646
Total liabilities & shareholders' equity158,800158,831163,139
Total common shares outstanding353738
Treasury shares - common primary issue2.021.972.59
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.